The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCEMP.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCCCP.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCPPS.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: These recertification activities are intended for board-certified pharmacists seeking to update their knowledge and skills in:
- Evidence-based insights to improve treatment outcomes, avoid unnecessary healthcare costs, mitigate complications associated with central lines, and reduce morbidity and mortality
- Aspects of procedural sedation and commonly used agents for both sedation and analgesia
- Use of mainstay medications in RSI, induction agents and neuromuscular blocking agents, which assist with achieving first pass success
- Improve outcomes and approaches in patients with drug-induced hyperthermia (DIH)
Pharmacologic Controversies in Rapid Sequence Intubation - BCCCP / BCEMP CreditActivity Number: 0204-9999-25-212-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning ObjectivesPharmacologic Controversies in Rapid Sequence Intubation
- Select an optimal induction and paralytic agent for a patient using evidence-based guideline recommendations and recent literature.
- Develop a pharmacotherapy plan to prevent and/or treat peri-intubation hypotension.
- Critique cost-benefit related to the use of paralytic reversal agents both pre-intubation (in cannot intubate, cannot ventilate situations) and post-intubation.
|
Hot Takes on the Hot Body: Management of Drug-Induced Hyperthermia - BCEMP / BCCCP CreditActivity Number: 0204-9999-25-340-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning ObjectivesHot Takes on the Hot Body: Management of Drug-Induced Hyperthermia
- Recognize the signs and symptoms of drug-induced hyperthermia and its associated risk factors.
- Define the pharmacist’s role in drug-induced hyperthermia management and prevention.
- Develop streamlined processes for the identification and continued treatment of drug-induced hyperthermia in clinical settings.
- Describe the role of a drug-induced hyperthermia response team.
|
Beyond Counting Sheep: Inhaled and Procedural Sedation in the ED and ICU - BCPPS / BCCCP / BCEMP CreditActivity Number: 0204-9999-25-260-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning ObjectivesBeyond Counting Sheep: Inhaled and Procedural Sedation in the ED and ICU
- Evaluate current literature regarding agents used for sedation and analgesia in the setting of procedural sedation.
- Discuss patient-specific variables that have the potential to impact the safety and efficacy of the various pharmacotherapy options used in procedural sedation.
- Critique procedural sedation pharmacotherapy implementation strategies with the goal of optimizing pharmacokinetic and pharmacodynamic principles.
- Recognize options for alternative routes of administration and potential considerations based on patient-specific factors.
- Identify important components that should be included in workflows and protocols for procedural sedation (e.g., stocking atomizers for intranasal administration, antidotal therapy availability, bedside monitoring).
|
"Myth-Conceptions": Debunking Common Myths in Infectious Diseases - BCPPS / BCEMP CreditActivity Number: 0204-9999-25-306-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning Objectives"Myth-Conceptions": Debunking Common Myths in Infectious Diseases
- Describe prevalent myths in the treatment and management of infectious diseases in adult and pediatric patients.
- Practice effective antimicrobial stewardship within individual and institutional practice.
- Recommend optimal antibiotic use to prevent resistance and improve outcomes.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.